Cargando…
Two‐dimensional in vivo dose verification using portal imaging and correlation ratios
The electronic portal imaging device (EPID) has the potential to be used for in vivo dosimetry during radiation therapy as an additional dose delivery check. In this study we have extended a method developed by A. Piermattei and colleagues in 2006 that made use of EPID transit images (acquired durin...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875516/ https://www.ncbi.nlm.nih.gov/pubmed/25207402 http://dx.doi.org/10.1120/jacmp.v15i4.4752 |
_version_ | 1783310360954011648 |
---|---|
author | Peca, Stefano Brown, Derek W. |
author_facet | Peca, Stefano Brown, Derek W. |
author_sort | Peca, Stefano |
collection | PubMed |
description | The electronic portal imaging device (EPID) has the potential to be used for in vivo dosimetry during radiation therapy as an additional dose delivery check. In this study we have extended a method developed by A. Piermattei and colleagues in 2006 that made use of EPID transit images (acquired during treatment) to calculate dose in the isocenter point. The extension allows calculation of two‐dimensional dose maps of the entire radiation field at the depth of isocenter. We quantified the variability of the ratio of EPID signal to dose in the isocenter plane in Solid Water phantoms of various thicknesses and with various field sizes, and designed a field edge dose calculation correction. To validate the method, we designed three realistic conventional radiation therapy treatment plans on a thorax and head anthropomorphic phantom (whole brain, brain primary, lung tumor). Using CT data, EPID transit images, EPID signal‐to‐dose correlation, and our edge correction, we calculated dose in the isocenter plane and compared it with the treatment planning system's prediction. Gamma evaluation (3%, 3 mm) showed good agreement (P(γ<1) ≥ 96.5%) for all fields of the whole brain and brain primary plans. In the presence of lung, however, our algorithm overestimated dose by 7%–9%. This 2D EPID‐based in vivo dosimetry method can be used for posttreatment dose verification, thereby improving the safety and quality of patient treatments. With future work, it may be extended to measure dose in real time and to prevent harmful delivery errors. PACS numbers: 87.55.km, 87.55.Qr, 87.55.T‐ |
format | Online Article Text |
id | pubmed-5875516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58755162018-04-02 Two‐dimensional in vivo dose verification using portal imaging and correlation ratios Peca, Stefano Brown, Derek W. J Appl Clin Med Phys Radiation Oncology Physics The electronic portal imaging device (EPID) has the potential to be used for in vivo dosimetry during radiation therapy as an additional dose delivery check. In this study we have extended a method developed by A. Piermattei and colleagues in 2006 that made use of EPID transit images (acquired during treatment) to calculate dose in the isocenter point. The extension allows calculation of two‐dimensional dose maps of the entire radiation field at the depth of isocenter. We quantified the variability of the ratio of EPID signal to dose in the isocenter plane in Solid Water phantoms of various thicknesses and with various field sizes, and designed a field edge dose calculation correction. To validate the method, we designed three realistic conventional radiation therapy treatment plans on a thorax and head anthropomorphic phantom (whole brain, brain primary, lung tumor). Using CT data, EPID transit images, EPID signal‐to‐dose correlation, and our edge correction, we calculated dose in the isocenter plane and compared it with the treatment planning system's prediction. Gamma evaluation (3%, 3 mm) showed good agreement (P(γ<1) ≥ 96.5%) for all fields of the whole brain and brain primary plans. In the presence of lung, however, our algorithm overestimated dose by 7%–9%. This 2D EPID‐based in vivo dosimetry method can be used for posttreatment dose verification, thereby improving the safety and quality of patient treatments. With future work, it may be extended to measure dose in real time and to prevent harmful delivery errors. PACS numbers: 87.55.km, 87.55.Qr, 87.55.T‐ John Wiley and Sons Inc. 2014-07-08 /pmc/articles/PMC5875516/ /pubmed/25207402 http://dx.doi.org/10.1120/jacmp.v15i4.4752 Text en © 2014 The Authors. This is an open access article under the terms of the http://creativecommons.org/licenses/by/3.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Peca, Stefano Brown, Derek W. Two‐dimensional in vivo dose verification using portal imaging and correlation ratios |
title | Two‐dimensional in vivo dose verification using portal imaging and correlation ratios |
title_full | Two‐dimensional in vivo dose verification using portal imaging and correlation ratios |
title_fullStr | Two‐dimensional in vivo dose verification using portal imaging and correlation ratios |
title_full_unstemmed | Two‐dimensional in vivo dose verification using portal imaging and correlation ratios |
title_short | Two‐dimensional in vivo dose verification using portal imaging and correlation ratios |
title_sort | two‐dimensional in vivo dose verification using portal imaging and correlation ratios |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875516/ https://www.ncbi.nlm.nih.gov/pubmed/25207402 http://dx.doi.org/10.1120/jacmp.v15i4.4752 |
work_keys_str_mv | AT pecastefano twodimensionalinvivodoseverificationusingportalimagingandcorrelationratios AT brownderekw twodimensionalinvivodoseverificationusingportalimagingandcorrelationratios |